Medicare Enrolled

Dr. Ingela Pezzolesi, M.D.

Family Medicine · Silverdale, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
9398 RIDGETOP BLVD NW, Silverdale, WA 98383
3607823200
In practice since 2006 (20 years)
NPI: 1235167180 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pezzolesi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pezzolesi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pezzolesi

Dr. Ingela Pezzolesi is a family medicine specialist in Silverdale, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pezzolesi performed 8,456 Medicare services across 2,125 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pezzolesi received a total of $1,785 from 17 pharmaceutical and/or device companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pezzolesi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in WA $1,785 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,456
Medicare services
Top 0% in WA for family medicine
2,125
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~423 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 5,820 $18 $64
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
629 $77 $366
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
624 $55 $259
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
257 $127 $372
Annual wellness visit, initial visit
A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment.
206 $163 $476
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
149 $9 $67
Assessment of emotional or behavioral problems
An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns.
116 $3 $16
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
102 $2 $7
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
88 $30 $86
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
85 $271 $766
SARS-CoV-2 vaccine, 30 mcg/0.3 mL
Administration of the SARS-CoV-2 (COVID-19) vaccine containing 30 micrograms of antigen in a 0.3 milliliter dose.
66 $41 $113
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $33 $162
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
43 $31 $87
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
37 $76 $206
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
35 $10 $43
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
29 $17 $68
Knee X-ray, 3 views
An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures.
22 $22 $93
Hip X-ray, 2-3 views
An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures.
19 $30 $106
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
18 $83 $329
Transitional care management services, moderate complexity
Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity.
17 $159 $588
Initial preventive physical examination, new Medicare beneficiary
A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care.
17 $164 $477
SARS-CoV-2 vaccine, 30 mcg/0.3 mL dose
Administration of a 30 mcg/0.3 mL dose of the SARS-CoV-2 vaccine.
14 $41 $113
Ear wax removal by washing
This procedure involves the removal of impacted ear wax using a washing technique.
13 $12 $51
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,785
Total received (2018-2024)
Avg $357/year across 5 years
Top 11% in WA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
116
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,546 (86.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$240 (13.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$189
2023
$29
2022
$395
2019
$732
2018
$441

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$161
Bayer Healthcare Pharmaceuticals Inc.
$14
Otsuka America Pharmaceutical, Inc.
$13
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$421
Bayer HealthCare Pharmaceuticals Inc.
$209
Takeda Pharmaceuticals U.S.A., Inc.
$196
ABBVIE INC.
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$150
PFIZER INC.
$148
Novo Nordisk Inc
$127
Astellas Pharma US Inc
$124
Allergan Inc.
$52
Merck Sharp & Dohme Corporation
$38
Amgen Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$30
Otsuka America Pharmaceutical, Inc.
$27
Supernus Pharmaceuticals, Inc.
$22
Amarin Pharma Inc.
$17
Teva Pharmaceuticals USA, Inc.
$14
Lilly USA, LLC
$12
Top 3 companies account for 46.3% of all-time payments
Associated products mentioned in payments ›
AUSTEDO · Aimovig · BYDUREON · CHANTIX · COLOGUARD · CREON · EUCRISA · EVENITY · FARXIGA · FASENRA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LYRICA · MYRBETRIQ · Ozempic · PRADAXA · PREVNAR - 13 · QULIPTA · REXULTI · ROTATEQ · Repatha · STIOLTO RESPIMAT · SYMBICORT · TROKENDI XR · TRULICITY · TRUMENBA · Trintellix · VRAYLAR · Vascepa · Victoza · Vyvanse
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Silverdale?
Compare family medicine physicians in the Silverdale area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,431
Per 100K population
517.4
County median income
$98,546
Nearest hospital
HARRISON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pezzolesi is a clinical cardiology specialist, with above-average Medicare volume (top 0% in WA), with low-engagement industry engagement in the top 11% of WA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pezzolesi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Pezzolesi performed 5,820 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pezzolesi receive payments from pharmaceutical companies?
Yes. Dr. Pezzolesi received a total of $1,785 from 17 companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pezzolesi's costs compare to other family medicine physicians in Silverdale?
Dr. Pezzolesi's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pezzolesi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →